MS relapse rates before and during pregnancy — not the decision to breast-feed — predicted the likelihood of postpartum relapses.
Many specialists in multiple sclerosis (MS) withhold disease-modifying MS therapies during breast-feeding because these agents are excreted in milk. Does extended breast-feeding have an effect on postpartum relapse rates? To find out, researchers followed 298 women (302 pregnancies) in Italy for at least 1 year after delivery. About one third chose to breast-feed for at least 2 months; most of that subgroup (28% of the entire cohort) breast-fed for at least 6 months.
Conventional statistical analyses suggested that prepartum MS relapse rates were similar between women who breast-fed and those who did not. However, a more powerful analysis accounting for potential confounders showed that women who breast-fed had significantly lower MS relapse…
Reviewing Author
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)